Sangamo Therapeutics


Sangamo Therapeutics Stock Quote
$9.57 -$0.38 0.0%
BATS BZX Real Time Price as of June 24, 2019, 4:00 p.m. View Interactive SGMO Charts

The Company deals in the research, development and commercialization of DNA-binding proteins for the therapeutic regulation and modification of disease-related genes.

News & Analysis: Sangamo Therapeutics

The Fool has written over 100 articles on Sangamo Therapeutics.


Market Moves


5 Top Gene-Editing Stocks for 2019

The future of treating disease might be gene editing, and these five stocks have the most promising technologies.

Interactive Chart